Insight Analysis of Promiscuous Estrogen Receptor α-Ligand Binding by a Novel Machine Learning Scheme.

Chemical Research in Toxicology
Tien-Yi HouMax K Leong

Abstract

Estrogen receptor α (ERα) plays a significant role in occurrence of breast cancer and may cause various adverse side-effects when ERα is an off-target protein. A theoretical model was derived to predict the binding affinity of ERα using the pharmacophore ensemble/support vector machine (PhE/SVM) scheme to consider the promiscuous characteristic of ERα. The estimations by PhE/SVM were discovered to be in good agreement with the observed values for those training molecules ( n = 31, r2 = 0.80, qCV2 = 0.77, RMSE = 0.57, s = 0.58), test molecules ( n = 179, q2 = 0.91-0.96, RMSE = 0.33, s = 0.26) and outliers ( n = 15, q2 = 0.80-0.86, RMSE = 0.56, s = 0.49). When subjected to various statistical validations, the PhE/SVM model consistently fulfilled the strictest criteria. A mock test also asserted its predictivity. When compared with crystal structures, the calculated results are consistent with the reported ERα-ligand co-complex structure, and the plasticity nature of ERα is also disclosed. Consequently, this precise, fast, and robust model can be adopted to predict ERα-ligand binding affinities and to design safer non-ERα-targeted pharmaceuticals in the process of drug discovery and development.

References

Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Oct 24, 1997·Nature·A M BrzozowskiM Carlquist
Dec 5, 1997·The Journal of Comparative Neurology·P J ShughrueI Merchenthaler
Dec 17, 1997·The Journal of Clinical Endocrinology and Metabolism·E EnmarkJ A Gustafsson
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·D M TanenbaumP B Sigler
Feb 13, 2001·The Journal of Steroid Biochemistry and Molecular Biology·J A Gustafsson, M Warner
Feb 24, 2001·Journal of Chemical Information and Computer Sciences·L M ShiD M Sheehan
Mar 27, 2002·Endocrine-related Cancer·C PalmieriJ-A Gustafsson
Jun 1, 2002·Science·Donald P McDonnell, John D Norris
Feb 5, 2003·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Sep 19, 2003·Journal of Computer-aided Molecular Design·Alexander GolbraikhAlexander Tropsha
Mar 10, 2004·Bioorganic & Medicinal Chemistry Letters·Helen Y ChenMilton L Hammond
Apr 20, 2004·Critical Reviews in Oncology/hematology·Sandra Timm Pearce, V Craig Jordan
May 6, 2004·Bioorganic & Medicinal Chemistry Letters·Seongkon KimMilton L Hammond
Jun 19, 2004·Bioorganic & Medicinal Chemistry Letters·Qiang TanMilton L Hammond
Jun 19, 2004·Bioorganic & Medicinal Chemistry Letters·Qiang TanMilton L Hammond
Jul 1, 2004·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Jul 1, 2004·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Nov 19, 2004·Journal of the American Chemical Society·Eric S ManasJuan C Alvarez
Dec 8, 2004·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Dec 8, 2004·Endocrine Reviews·Matthew H Herynk, Suzanne A W Fuqua
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eric H KongAshley C W Pike
Mar 5, 2005·Bioorganic & Medicinal Chemistry Letters·Qiang TanMilton L Hammond
Jul 5, 2005·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Oct 6, 2005·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Aug 18, 2006·Molecular Aspects of Medicine·Paolo AscenziMaria Marino
Feb 7, 2007·The Journal of Biological Chemistry·Nina HeldringAshley C W Pike
Feb 10, 2007·Bioorganic & Medicinal Chemistry Letters·Kevin D DykstraMilton L Hammond
Apr 24, 2007·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Apr 26, 2007·Protein Science : a Publication of the Protein Society·Felix F VajdosJayvardhan Pandit
May 1, 2007·EMBO Reports·Kendall W NettlesGeoffrey L Greene
May 5, 2007·Journal of Chemical Information and Modeling·David A EvansMichael J Bodkin
Sep 25, 2007·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Jan 15, 2008·Drug Discovery Today·Gerhard WolberThierry Langer
May 20, 2008·Journal of Computational Chemistry·Jiazhong LiPaola Gramatica

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.